Abstract
Atherosclerosis predominates as the pathologic lesion in coronary artery disease. Less commonly, other nonatherosclerotic etiologic processes involve the coronary arteries, with or without symptoms. This chapter explores the nonatherosclerotic etiologies of coronary artery disease, from spontaneous and device-induced vasospasm to spontaneous coronary artery dissection, vasculitis, embolism, aneurysm, and microcirculatory coronary disease to the impact of chest irradiation, heart valve transplants, congenital conditions, and cocaine use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Maseri A, Chierchia S. Coronary artery spasm: demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Dis. 1982;25:169–92.
Heupler FA, Proudfit WL, Razavi M, et al. Ergonavine maleate provocative test for coronary artery spasm. Am J Cardiol. 1978;41:631–40.
Bertrand ME, LaBlance JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982;65:1299–308.
Bentivoglio LG, Leo LR, Wolf NM, et al. Frequency and importance of unprovoked coronary spasm in patients with angina pectoris undergoing percutaneous transluminal coronary angioplasty. Am J Cardiol. 1983;51:1067–71.
Bott-Silverman C, Heupler FA, Yiannikas J. Variant angina: comparison of patients with and without fixed severe coronary artery disease. Am J Cardiol. 1984;54:1173–5.
Mark DB, Califf RM, Morris KG, et al. Clinical characteristics and long-term survival of patients with variant angina. Circulation. 1984;69:880–8.
Egashira K, Kikuchi Y, Sagara T, et al. Long-term prognosis of vasospastic angina without significant atherosclerotic coronary artery disease. Jpn Heart J. 1987;28:841–9.
Nobuyoshi M, Tanaka M, Nosaka H, et al. Progression of atherosclerotis: is coronary spasm related to progression? J Am Coll Cardiol. 1991;18:904–10.
Harding MB, Leithe ME, Mark DB, et al. Ergonavine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal’s variant angina. J Am Coll Cardiol. 1992;20:107–11.
Carlis DG, Deligonul U, Kern MJ, et al. Smoking is a risk factor for coronary spasm in young women. Circulation. 1992;85:905–9.
Nakano T, Osanai T, Yomita H, et al. Enhanced activity of variant phospholipase C-1 protein (R257H) detected in patients with coronary artery spasm. Circulation. 2002;105:2024–9.
Suzuki S, Yoshimura M, Nakayama M, et al. A novel genetic marker for coronary spasm in women from a genome-wide single nucleotide polymorphism analysis. Pharmacogenet Genomics. 2007;17:919–30.
Ginsburg R, Schroeder JS. Coronary spasm producing coronary thrombosis. N Engl J Med. 1983;309:648.
Oliva PB, Potts DE, Plus RG. Coronary arterial spasm in Prinzmetal angina. N Engl J Med. 1973;288:745–51.
Schroeder JS, Bolen JL, Quint RA, et al. Provocation of coronary spasm with ergonovine maleate. Am J Cardiol. 1977;40:487–91.
Curry RC, Pepine CJ, Sabom MB, et al. Effects of ergonavine in patients with and without coronary artery disease. Circulation. 1977;56:804–9.
Chahine RA, Raizner AE, Ishimori T, et al. The incidence and clinical implications of coronary artery spasm. Circulation. 1975;52:972–8.
Curry RC, Pepine CJ, Sabom MB, et al. Hemodynamic and myocardial metabolic effects of ergonavine in patients with chest pain. Circulation. 1978;58:648–54.
Suzuki Y, Tokunaga S, Ikeguchi S, et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J. 1992;124:39–47.
Wright CM, Engler R, Maisel A. Coronary thrombosis precipitated by hyperventilation-induced vasospasm. Am Heart J. 1988;116:867–9.
Ginsburg R, Bristow MR, Kantrowitz N, et al. Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J. 1981;102:819–22.
Feldman RL, Curry RC, Pepine CJ, et al. Regional coronary hemodynamic effects of ergonovine in patients with and without variant angina. Circulation. 1980;62:149–59.
Kugiyama K, Ohgushi M, Motoyama T, et al. Enhancement of constrictor response of spastic coronary arteries to acetylcholine but not to phenylephrine in patients with coronary spastic angina. J Cardiovasc Pharmacol. 1999;33:414–9.
Magder SA, Johnstone DE, Huckell VF, et al. Experience with ergonovine provocative testing for coronary arterial spasm. Chest. 1981;79:638–46.
Kodma K, Yamagishi M, Nanto S, et al. Comparison of coronary hemodynamic and cardiac metabolic alterations during coronary spasm associated with ST segment elevation or depression. Jpn Circ J. 1985;49:422–31.
Whittle JL, Feldman RL, Pepine CJ, et al. Variability of electrocardiographic responses to repeated ergonovine provocation in variant angina patients with coronary artery spasm. Am Heart J. 1982;103:161–7.
Matsuda Y, Ogawa H, Moritani K, et al. Transient appearance of collaterals during vasospastic occlusion in patients without obstructive coronary atherosclerosis. Am Heart J. 1985;109:759–63.
Takeshita A, Koiwaya Y, Nakamura M, et al. Immediate appearance of collaterals during ergonovine-induced arterial spasm. Chest. 1982;82:319–22.
Maleki M, Manley JC. Venospastic phenomena in saphenous vein grafts: possible causes for unexplained postoperative recurrence of angina or early or late occlusion of vein bypass grafts. Br Heart J. 1989;62:57–60.
Hosio A, Kotake H, Mashiba H. Significance of coronary artery tone in patients with vasospastic angina. J Am Coll Cardiol. 1989;14:604–9.
Hill JA, Feldman RL, Pepine CJ, et al. Regional coronary artery dilation response in variant angina. Am Heart J. 1982;104:226–33.
Kaski JC, Maseri A, Vejar M, et al. Spontaneous coronary artery spasm in variant angina is caused by a local hyperactivity to a generalized constrictor stimulus. J Am Coll Cardiol. 1989;14:1456–63.
Feldman RL, Pepine CJ, Whittle JL, et al. Coronary hemodynamic findings during spontaneous angina in patients with variant angina. Circulation. 1981;64:76–83.
Deckelbaum LI, Isner JM, Konstam MA, et al. Catheter-induced versus spontaneous spasm – do these coronary bedfellows deserved to be estranged? Am J Med. 1985;79:1–4.
Schwartz RE, Butman S. Catheter-induced nonproximal coronary artery spasm. Am J Cardiol. 1984;53:352–4.
Rabih R, Azar I. Diffuse coronary spasm in a patient with a recent stent. JACC Cardiovasc Interv. 2010;3:459–60.
DeMaio S, Kinsella SH, Silverman ME. Clinical course and long-term prognosis of spontaneous coronary artery dissection. Am J Cardiol. 1989;64:471–4.
Bulkley BH, Roberts WC. Dissecting aneurysm (hematoma) limited to coronary artery. Am J Med. 1973;55:747–56.
Mathieu D, Larde D, Vasile N. Primary dissecting aneurysms of the coronary arteries: case report and literature review. Cardiovasc Intervent Radiol. 1984;7:71–4.
Claudon DG, Claudon DB, Edwards JE. Primary dissecting aneurysm of coronary artery. Circulation. 1972;45:259–66.
Brody GL, Burton JF, Zawadzki ES, et al. Dissecting aneurysm of the coronary artery. N Engl J Med. 1965;273:10–5.
Yeoh J, Choo H, Soo C, et al. Spontaneous coronary artery dissection in a young man with anterior myocardial infarction. Cathet Cardiovasc Diagn. 1991;24:186–8.
Heilbrunn A, Zimmerman JM. Coronary artery dissection: a complication of cannulation. J Thorac Cardiovasc Surg. 1965;49:767.
Roy P, Finci L, Boop P, et al. Emergency balloon angioplasty and digital subtraction angiography in the management of an acute iatrogenic occlusive dissection of a saphenous vein graft. Cathet Cardiovasc Diagn. 1989;16:176–9.
Thayer JO, Healy RW, Maggs PR. Spontaneous coronary artery dissection. Ann Thorac Surg. 1987;44:97–102.
Orbe LC, Gallego FG, Sobrino N, et al. Acute myocardial infarction after blunt chest trauma in young people. Cathet Cardiovasc Diagn. 1991;24:182–5.
Lee FH, Yeung AC, Fowler MB, et al. Spontaneous postpartum dissection. Circulation. 1999;99:271.
Rabinowitz M, Virmani R, McAllister H. Spontaneous coronary artery dissection and eosinophilic inflammation: a cause and effect relationship? Am J Med. 1982;72:923–7.
Nishikawa H, Nakanishi S, Nishiyama S, et al. Primary coronary dissection observed at coronary angiography. Am J Cardiol. 1988;61:645–8.
Alvarez J, Deal CW. Spontaneous dissection of the left main coronary artery: case report and review of the literature. Aust N Z J Med. 1991;21:891–2.
Himbert D, Makowski S, Laperche T, et al. Left main coronary spontaneous dissection: progressive angiographic healing without coronary surgery. Am Heart J. 1991;22:747–56.
Behnan R, Tillinghast S. Thrombolytic therapy in spontaneous coronary dissection. Clin Cardiol. 1991;14:611–4.
Vale PR, Baron DW. Coronary stenting for spontaneous coronary dissection: a case report and review of the literature. Cathet Cardiovasc Diagn. 1998;45:280–6.
Betriu A, Pare JC, Sanz GA, et al. Myocardial infarction in normal coronary arteries: a prospective clinical-angiographic study. Am J Cardiol. 1981;48:28–38.
Rigatelli G, Rossi P, Docali G. Normal angiogram in acute coronary syndromes: the underestimated role of alternative substrates of myocardial ischemia. Int J Cardiovasc Imaging. 2004;20:471–5.
Thompson SI, Vieweg WVR, Alpert JS, et al. Incidence and age distribution of patients with myocardial infarction and normal coronary arteriograms. Cathet Cardiovasc Diagn. 1977;3:1–9.
Thompson EA, Ferraris S, Gress T, et al. Gender differences and predictors of mortality in spontaneous coronary artery dissection: a review of reported cases. J Invasive Cardiol. 2005;17:59–61.
Cipriano PR, Koch FH, Rosenthal SJ, et al. Myocardial infarction in patients with coronary spasm demonstrated by angiography. Am Heart J. 1983;105:542–7.
Gersh BJ, Chesebro JH, Bove AA. Myocardial infarction with angiographically “normal:” coronary arteries: is this rapid progression of early coronary artery disease? Chest. 1984;84:654–6.
Legrand V, Deliege M, Henrard L, et al. Patients with myocardial infarction and normal coronary arteries. Chest. 1982;82:678–85.
Lindsay J, Pichard AD. Acute myocardial infarction with normal coronary arteries. Am J Cardiol. 1984;54:902–4.
Rosenblatt A, Selzer A. The nature and clinical features of myocardial infarction with normal coronary arteriogram. Circulation. 1977;55:578–80.
Ciraulo DA, Bresnahan GF, Frankel PS, et al. Transmural myocardial infarction with normal coronary arteriograms and with single vessel coronary obstruction. Chest. 1983;83:196–202.
Glover MU, Kuber MT, Warren SE, et al. Myocardial infarction before age 36: risk factor and arteriographic analysis. Am J Cardiol. 1982;49:1600–3.
Smith HWB, Liberman HA, Brody SL, et al. Acute myocardial infarction temporally related to cocaine use: clinical, angiographic and pathophysiologic observations. Ann Intern Med. 1987;107:13–8.
Sharkey SW, Windenburg DC, Lesser JR, et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010;55:333–41.
Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472–9.
Likoff W, Segal BL, Kasparian H. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N Engl J Med. 1967;276:1063.
Kemp HG. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol. 1973;32:375.
Cannon RO, Schenke WH, Leon MB, et al. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Circulation. 1987;75:163.
Cannon RO, Schenke WH, Leon MB, et al. Limited coronary flow reserve in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation. 1985;7:218.
Cannon RO. Microvascular angina. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 3rd ed. New York: WB Saunders; 1991. p. 343–50.
Geltman EM, Henes CG, Senneff MJ, et al. Increased myocardial perfusion at rest and diminished perfusion reserved in patient with angina and angiographically normal coronary arteries. J Am Coll Cardiol. 1990;16:586–95.
Lanza G, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317–25.
Opherk D, Schwartz F, Mall G, et al. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients. Am J Cardiol. 1983;51:1657–62.
Brush JE, Cannon RO, Schenke WH, et al. Angina due to microvascular disease, in hypertensive patients without left ventricular hypertrophy. N Engl J Med. 1988;319:1302–7.
Ryan TJ, Treasure CB, Yeung AC, et al. Impaired endothelium-dependent dilation of the coronary microvasculature in patients with atherosclerosis [abstract]. Circulation. 1991;84:II624.
Selke FW, Armstrong ML, Harrison DC. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation. 1990;81:586.
Wilson RF, Marcus ML, White CW. Prediction of the significance of coronary arterial lesions by quantitative coronary angiography in patients with limited coronary artery disease. Circulation. 1987;75:723–32.
Wilson RF, Laughlin DE, Ackell PH, et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation. 1985;72:82.
McGinn AL, White CW, Wilson RF. Interstudy variability of coronary flow reserve: influence of heart rate, arterial pressure, and ventricular preload. Circulation. 1990;81:1319–28.
Wilson RF, Christensen BV, Zimmer S, et al. The effects of adenosine on human coronary circulation. Circulation. 1990;82:1595–606.
Wilson RF, Marcus ML, Christensen BV, et al. The accuracy of exercise electrocardiography in predicting the physiologic significance of coronary arterial stenosis. Circulation. 1991;83:412–21.
Egashira K, Inou T, Hirooka Y, et al. Evidence of impaired endothelium dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659–64.
Zir LM, Miller SW, Dinsmore RE, et al. Interobserver variability in coronary arteriography. Circulation. 1976;53:627–32.
Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046–51.
Fish RP, Nabel EG, Selwyn AP, et al. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988;81:21–31.
Vogt M, Rabenau O, Motz W, et al. Evidence of endothelial dysfunction in patients with angina pectoris and angiographically normal coronary arteries [abstract]. Circulation. 1989;80:II436.
McReynolds RA, Gold GL, Roberts WC. Coronary heart disease after mediastinal irradiation for Hodgkin disease. Am J Med. 1976;60:39–45.
Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin disease. JAMA. 1993;270:1949–55.
Reinders JG, Heijmen BJ, Olofsen-van-Acht MJ, et al. Ischemic heart disease after mantle field irradiation for Hodgkin disease in long-term follow-up. Radiother Oncol. 1999;51:35–42.
Steward JR, Cohn KE, Fajardo LF, Hancock EW, et al. Radiation-induced heart disease. Radiology. 1967;89:302–10.
Pohjola-Sintonen S, Totterman KJ, Almo M, et al. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin disease. Cancer. 1987;60:31–7.
Brosius FC, Waller BF, Roberts WC. Radiation heart disease: analysis of 16 young (aged 15–33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med. 1981;70:519–30.
Theodoulou M, Seiman AD. Cardiac effects of adjuvant therapy for early breast cancer. Semin Oncol. 2003;30:730–9.
Tracy GP, Brown DE, Johnson LW, et al. Radiation-induced coronary artery disease. JAMA. 1974;228:1660–2.
Prentice RTW. Myocardial infarction following radiation. Lancet. 1965;2:388.
Rademaker J, Schoder H, Ariaratnam NS, et al. Coronary artery disease after radiation therapy for Hodgkin lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. Am J Radiol. 2008;191:32–7.
Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin disease: an analysis of technique, tumor eradication and complications. Cancer. 1976;37:2813–25.
Ogum S, Okazaki H, Jimbo M, et al. Vascular rejection and arteriosclerosis. Transplant Proc. 1987;19:63–70.
Schmauss D, Weis M. Cardiac allograft vasculopathy. Recent developments. Circulation. 2008;117:2131–41.
Pucci AM, Forbes RDC, Billingham ME. Pathologic features in long-term cardiac allografts. J Heart Transplant. 1990;9:339–45.
Johnson DE, Gao SZ, Schroeder JS, et al. The spectrum of coronary artery pathologic findings in heart cardiac allografts. J Heart Transplant. 1989;8:349–59.
Libby P, Salomon RN, Payne DD, et al. Functions of vascular wall cell related to development of transplantation-associated coronary atherosclerosis. Transplant Proc. 1989;21:3677–84.
Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12:334–40.
Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients. Circulation. 1987;76:827–34.
Gao SZ, Alderman EL, Schroeder JS, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Circulation. 1989;80(Suppl III):100–5.
Olivari MT, Homans DC, Wilson RF, et al. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. Circulation. 1989;80(Suppl III):111–5.
Gao SZ, Alderman EL, Schroeder JS, et al. Progressive coronary luminal narrowing after cardiac transplantation. Circulation. 1990;82(Suppl IV):269–75.
Nitkin RS, Hunt SA, Schroeder JS. Accelerated atherosclerosis in a cardiac transplant patient. J Am Coll Cardiol. 1985;6:243–5.
Mulvagh SL, Thornton B, Frazier OH, et al. The older cardiac transplant donor: relation to graft function and recipient survival longer than 6 years. Circulation. 1989;80(Suppl III):126–32.
O’Neill B, Pflugfelder PW, Singh NR, et al. Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. Am J Cardiol. 1989;63:1221–3.
Sharples LD, Mullin PA, Cary NRB, et al. A method of analyzing the onset and progression of coronary occlusive disease after transplantation and its effect on patient survival. Transplantation. 1993;12:381–7.
Kapadia SR, Nissen SE, Ziada KM, et al. Impact of intravascular ultrasound in understanding transplant coronary artery disease. Curr Opin Cardiol. 1999;14(2):140–50.
Kapadia SR, Nissen SE, Ziada KM, et al. Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging. Circulation. 1998;98(24):2672–8.
Gao HZ, Hunt SA, Alderman EL, et al. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol. 1997;29(3):623–9.
Davis SF, Yeung AC, Meredith IT, et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year post-transplant. Circulation. 1996;93(3):457–62.
McGinn AL, Christensen BV, Meyer S, et al. Early impairment of nitroglycerin-induced coronary dilation after human cardiac transplantation [abstract]. J Am Coll Cardiol. 1991;17(2):309A.
Vlodaver Z, Neufeld HN, Edwards JE. Coronary arterial variations in the normal heart and in congenital heart disease. New York: Academic; 1975.
Fulton WF. The coronary arteries. Springfield: Charles C. Thomas; 1965.
Ottervanger JP, Wilson JH, Stricker BH. Drug-induced chest pain and myocardial infarction. Report to a national center and review of the literature. Eur J Clin Pharmacol. 1997;53(2):105–10.
Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women of the United States. Circulation. 2005;111:472–9.
Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) study group. Acad Emerg Med. 1994;1:330–9.
Weber EJ, Chudnofsky CR, Boczar M, Boyer EW, Wilkerson MD, Hollander JE. Cocaine associated chest pain, how common is myocardial infarction? Acad Emerg Med. 2000;7:873–7.
McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction. Circulation. 2008;117:1897–907.
Forrester JM, Steele AW, Waldron JA, Parsons PE. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis. 1990;42:462–7.
Brogan III WC, Lange RA, Kim AS, et al. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991;18:581–6.
Kontos MC, Jesse RJ, Tatum JL, Ornato JP. Coronary artery findings in patients with cocaine-associated chest pain. J Emerg Med. 2003;24:9–13.
Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345:351–67.
Walley VM, Giannoccaro P, Beanlands DS, et al. Dead at cardiac catheterization: coronary artery embolization of calcium debris from Ionescu-Shiley bioprosthesis. Cathet Cardiovasc Diagn. 1990;21:92–4.
Johnson D, Gonsalez-Lavin L. Myocardial infarction secondary to calcific embolization: an unusual complication of bioprosthetic valve degeneration. Ann Thorac Surg. 1986;42:102–3.
Tannike M, Nishino M, Egami Y, et al. Acute myocardial infarction caused by septic coronary embolism diagnosed and treated with thrombectomy catheter. Heart. 2005;91(5):e34.
Vlodaver Z, Neufeld HN, Edwards JE. Pathology of angina pectoris. Circulation. 1972;46:1048–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Valeti, U.S., Wilson, R.F., Vlodaver, Z. (2012). Nonatherosclerotic Ischemic Heart Disease. In: Vlodaver, Z., Wilson, R., Garry, D. (eds) Coronary Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1475-9_20
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1475-9_20
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1474-2
Online ISBN: 978-1-4614-1475-9
eBook Packages: MedicineMedicine (R0)